Key Insights

Highlights

Success Rate

81% trial completion

Published Results

25 trials with published results (17%)

Research Maturity

60 completed trials (40% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 49/100

Termination Rate

9.3%

14 terminated out of 151 trials

Success Rate

81.1%

-5.4% vs benchmark

Late-Stage Pipeline

9%

14 trials in Phase 3/4

Results Transparency

42%

25 of 60 completed with results

Key Signals

25 with results81% success14 terminated

Data Visualizations

Phase Distribution

131Total
Not Applicable (99)
P 1 (5)
P 2 (13)
P 3 (6)
P 4 (8)

Trial Status

Completed60
Recruiting29
Unknown26
Terminated14
Active Not Recruiting7
Not Yet Recruiting6

Trial Success Rate

81.1%

Benchmark: 86.5%

Based on 60 completed trials

Clinical Trials (151)

Showing 20 of 20 trials
NCT07061613Not ApplicableRecruitingPrimary

Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for Venous Leg Ulcers

NCT07335861Not ApplicableNot Yet RecruitingPrimary

Evaluation of the Efficacy of Hyalomatrix® in the Healing of Chronic Venous Leg Ulcers

NCT07538609Not ApplicableNot Yet Recruiting

The GORE® VIABAHN® FORTEGRA Venous Stent Post-Approval Study

NCT07123285Not ApplicableNot Yet Recruiting

Effect of Photobiomodulation on Healing of Venous Leg Ulcers

NCT05409976Not ApplicableActive Not Recruiting

The GORE® VIABAHN® FORTEGRA Venous Stent IVC Study

NCT06528873Phase 4RecruitingPrimary

COMS for Chronic Ulcers Treatment

NCT07541196Not ApplicableRecruiting

PAW-Hydrogel for Chronic Wound Healing

NCT04647240Phase 2Recruiting

MTX-001 for the Treatment of Non-Healing Venous Stasis Ulcers

NCT06181708CompletedPrimary

Diagnostics in the Leg Ulcer Pathway

NCT06453187Not ApplicableEnrolling By Invitation

A Modified Platform Trial of Multiple CAMPs for the Management of Diabetic Foot Ulcers and Venous Leg Ulcers

NCT06562296Phase 4Completed

Study Evaluating Several CAMPs in Nonhealing Diabetic Foot and Venous Leg Ulcers

NCT06930768Not ApplicableNot Yet RecruitingPrimary

Evaluating the Efficacy of NeoThelium FT in the Treatment of Venous Leg Ulcers

NCT05489588Not ApplicableRecruiting

The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study

NCT07211243Not ApplicableRecruitingPrimary

Suprasorb®X+PHMB Pro vs Suprasorb®X+PHMB in Treatment of Infected Venous Leg Ulcers

NCT07463365Phase 1Not Yet RecruitingPrimary

Phase 1 Study of LUT017 Gel to Evaluate Safety and Wound Healing in Adults With Venous Leg Ulcers and Chronic Non-Healing Skin Wounds

NCT06328010Enrolling By Invitation

Clinical Registry Collecting Real World Evidence on Wound Care Treatments

NCT04714749Not ApplicableCompletedPrimary

Feasibility and Tolerance Study for the Treatment of Varicose Ulcers by Cyanoacrylate Glue (ETUVVE)

NCT06515093Not ApplicableRecruiting

Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC

NCT04927702Not ApplicableTerminated

Assessment of Wound Closure Comparing Synthetic Hybrid-Scale Fiber Matrix With Standard of Care in Treating Diabetic Foot Ulcers (DFU) and With Living Cellular Skin Substitute in Treating Venous Leg Ulcers (VLU)

NCT06707090Phase 3RecruitingPrimary

Tissue Repair Gel in Venous Leg Ulcers (US)

Scroll to load more

Research Network

Activity Timeline